Some Ebola Patients Should Get Placebo in Drug Tests: FDA - (Bloomberg via NewsPoints Desk)

  • Edward Cox, director of the FDA’s Office of Antimicrobial Products, said Wednesday that some patients with Ebola need to forgo potentially life-saving treatments so researchers can see how they fare compared to those who receive the experimental drugs, Bloomberg reported.
  • Cox noted that randomised studies would be "challenging," but they are necessary and would compare "the best supportive care versus the best supportive care with a drug."
  • He added that the FDA has a meeting next week to hear from companies, which he did not disclose, producing experimental treatments, adding that "those products are out there in the news."
  • Cox said that in order to speed up the search for the best drug, the agency is planning to check on effectiveness at "multiple intervals" during the studies.

To read more NewsPoints articles, click here.